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The diagnosis and management of complex regional pain syndrome is often challenging.
Early diagnosis and intervention improve outcomes in most patients; however, some patients
will progress regardless of intervention. Multidisciplinary management facilitates care in
complex cases. The onset of signs and symptoms may be obvious or insidious; temporal
delay is a frequent occurrence. Difficulty sleeping, pain unresponsive to narcotics, swelling,
stiffness, and hypersensitivity are harbingers of onset. Multimodal treatment with hand
therapy, sympatholytic drugs, and stress loading may be augmented with anesthesia blocks.
If the dystrophic symptoms are controllable by medications and a nociceptive focus or nerve
derangement is correctable, surgery is an appropriate alternative. Chronic sequelae of
contracture may also be addressed surgically in patients with controllable sympathetically
maintained pain. (J Hand Surg 2011;36A:1553–1562. Copyright © 2011 by the American
Society for Surgery of the Hand. All rights reserved.)






























tsAFTER TRAUMA OR surgery, physiologic eventsand adaptations that contribute to pain (allo-dynia, hyperpathia, and cold sensitivity), dys-
trophic events, or impaired function are common. The
abnormal prolongation or persistence of these events
with persistent pain, cold sensitivity, autonomic dys-
function, microvascular abnormality, localized atrophy,
and functional impairment constitutes complex regional
pain syndrome (CRPS, also known as reflex sympa-
thetic dystrophy and algodystrophy). Complex regional
pain syndrome increases injury or surgical symptoms,
delays recovery, and may compound morbidity by sec-
ondary complicating events such as arthrofibrosis and
delayed healing. Complex regional pain syndrome can
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ncrease permanent impairment and strain the physi-
ian–patient relationship.
The purposes of this review were to define the sub-
ective and objective manifestations of CRPS, to outline
iagnostic criteria, discuss nonoperative and operative
reatment options, elucidate common myths and mis-
onceptions, and delineate standard-of-care issues.
EFINITIONS
omplex regional pain syndrome is a clinical entity
ithout a single pathognomic test or marker. Although
ultiple synonyms exist, the most common are reflex
ympathetic dystrophy, causalgia, and algodystrophy
Table 1).
Based on the recommendation from the International
ssociation for the Study of Pain, complex regional
ain type 1 entails pain syndrome, autonomic dysfunc-
ion, trophic changes, and functional impairment with-
ut an identifiable peripheral nerve component. This
ntity corresponds to traditional reflex sympathetic dys-
rophy. Complex regional pain syndrome type 2 in-
ludes the above and identifiable nerve involvement
classic causalgia). The lessening of symptoms and
linical improvement after sympatholytic intervention
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tsis defined as sympathetically maintained pain (SMP).
Failure of improvement after sympatholytic interven-
tion including pharmacologic intervention or sympa-
thetic blocks is termed sympathetically independent
pain. Pain may be nociceptive or neuropathic. The
former denotes a mechanical or inflammatory process
that serves as a constant or intermittent source of pain
initiation. “Neuropathic pain” refers to pain related to
peripheral nerve irritation or excitability from compres-
sion, neuroma, neuroma-in-continuity, or inflammation.
If this pain spreads beyond the normal distribution of
the involved nerve and is associated with autonomic
changes, trophic events, and functional impairment,
CRPS type 2 is defined.
WHY YOU SHOULD CARE
Postinjury and postoperative outcomes are negatively
affected by CRPS. The recovery course is prolonged,
complications are frequent, rehabilitation is impaired,
stiffness is common, functional results are inferior, time
to return to work is increased, litigation is increased,
and patient satisfaction is compromised. Patients with
poor outcomes and CRPS may be litigious. Further-
more, plaintiffs with CRPS who prevail in court have
increased monetary rewards. An understanding of the
TABLE 1. Definitions
Pain: An unpleasant emotional response associated with
actual or potential cellular damage
Analgesia: Absence of pain in response to an insult that
should produce pain
Nociception: Response to an unpleasant (noxious) stimulus
that produces pain in human subjects under normal
circumstances
Allodynia: Pain in a specific dermatomal or autonomous
distribution associated with light touch to the skin; a
stimulus that is not normally painful
Hyperalgesia: Increased sensitivity to stimulation (includes
allodynia and hyperesthesia)
Hyperesthesia: Increased sensitivity to stimulation (pain on
response to a mild nonnoxious stimulus)
Sympathetic pain: Pain in the presence of or associated with
overaction of the sympathetic pain fibers; by definition, the
pain is relieved by sympatholytic interventions
Hypoesthesia: Decreased sensitivity to stimulation
Hyperpathia: Abnormally painful reaction to a stimulus
(especially repetitive); often includes extended duration of
pain, frequently with a delay
Dysesthesia: An unpleasant abnormal sensation
Paresthesia: An abnormal sensationclinical subtleties and manifestations of CRPS are cru-
JHS Vol A, Secial in improving patient outcomes and decreasing lia-
bility. In patients with persistent pain and refractory
symptoms—especially stiffness—CRPS should be in
the differential diagnosis, and that deliberation, positive
or negative, should be recorded.
Incidence/prevalence
The incidence and prevalence of CRPS are unknown;
however, its incidence is higher in smokers versus non-
smokers1 and it occurs 3 to 4 times more often in
women than in men.2 In Olmsted County, Minnesota,
the incidence was reported as 5.5 per 100,000 and the
prevalence as 20.7 per 100,000 in 2003.3 The incidence
after fracture of the distal radius varies from 4% to 39%
in prospective series and may occur after carpal tunnel
release with or without iatrogenic damage.4–6
Anatomy and physiology of pain
Pain with cellular damage initiated in the periphery may
be from mechanical, thermal, chemical, and ischemic
events. Pain signals, potentiated by local reflexes and
humeral factors, are relayed via peripheral nerves to the
dorsal horn of the spinal cord (wide dynamic range
neurons), where they may be amplified and modified
and then transmitted to cortical centers. The magnitude
of pain depends on the mechanisms of initiating events,
afferent information transmitted, efferent modulation,
and central nervous system interpretation (Fig. 1). Pain-
ful (nociceptive) information is activated peripherally
by mechanical, thermal, chemical, and ischemic events
and transmitted by small myelinated (A-) and small
unmyelinated C-afferent peripheral nerve fibers to the
spinal cord. The perception and physiologic conse-
quences are related to a complex interplay of physio-
logic events and psychological factors. Complex re-
gional pain syndrome is conceptually an exaggeration
or abnormal prolongation of the expected pathophysi-
ologic events after injury or surgery.
Complex regional pain syndrome may result in irre-
versible end-organ dysfunction, including loss of the
normal arteriovenous shunt mechanisms and permanent
alterations in central neurologic responses. Ongoing
segmental ischemic and cell death may have a substan-
tial role in the process. Swelling and stiffness, and
atrophy and contracture may occur and persist. Pain is
often associated with arteriovenous shunting and a rel-
ative ischemia of the extremity, mechanical events, or
nerve irritation.
Natural history
Complex regional pain syndrome types 1 and 2 occur,
in part, as a departure from the orderly and predictable
ptember 
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tsresponse of an extremity to a traumatic or surgical
insult. The exact pathophysiologic cause is not well
defined. A transient dystrophic response with pain, hy-
persensitivity, and altered autonomic function (abnor-
mal physiology) to injury or trauma is normal. How-
ever, an abnormal prolongation of this response and
inability of the patient to modulate or control the pain
cycle appears to be the best explanation of CRPS. A
cascade of reversible and irreversible events may ensue.
Because many drugs (pharmaceutical agents) and ther-
apies modify the natural history, it is defined poorly.
Dogma states that 80% of those treated within 1 year of
injury show considerable subjective and objective im-
provement, and approximately only 50% of those
treated after 1 year improve markedly.7 However, pa-
tients with CRPS after a fracture of the distal radius
have a poorer prognosis, with stiffness and “poor finger
function” at 3 months being correlated with morbidity
at 10 years.8 Despite early and appropriate treatment,
some patients do poorly, with long-term functional im-
FIGURE 1: Abnormal central nerve system modulation of a
dystrophic response after peripheral trigger (hammer striking supairment, chronic pain, or deformity; arbitrary time
JHS Vol A, Seframes that do not incorporate pharmacologic, mechan-
ical, and patient activity are not predictive.
Clinical manifestations and diagnosis
History, physical examination findings, and diagnostic
workup are extremely important. Suspicion that CRPS
may be a concern is important, and CRPS should be
considered in patients with unexpectedly intense pain,
difficulty sleeping, stiffness, slower than anticipated
recovery, and no pain relief with narcotics. A history of
a surgical or traumatic insult (whether minor or major)
is common. Typical pain is described as tearing or
burning and is exacerbated often by exposure to cold.
Pain is not relieved often or completely by narcotic
analgesics and responds frequently to sympatholytic
medications. Difficulty sleeping, restlessness, and anx-
iety are common. On examination, patients may exhibit
allodynia (painful response to a nonpainful stimulus),
hyperpathia (increased pain sensitivity), and hyperalge-
sia (increased sensitivity to stimulations). Functional
nt sensory stimuli may contribute to the development of a
cial radial nerve).fferedeficits occur owing to pain and swelling, which com-
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tsmonly result in stiffness of the fingers, wrist, and shoul-
der. Trophic changes from autonomic dysfunction in-
clude abnormal sweating, swelling, and changes in skin
temperature and texture. The involved extremity is ei-
ther swollen and warm or atrophic and cool. Although
women are more frequently affected than men, anyone
can be affected. Children and adolescents are afflicted
rarely but may manifest with severe involvement. The
incidence of upper versus lower extremity involvement
is similar. An identifiable mechanical trigger, nerve
involvement, or identifiable injury is present in less than
50% of cases.
Diagnostic tests
Plain x-rays may be normal but often show osteoporosis
with subchondral and periarticular resorption (Fig. 2).
These changes may not be visible for 2 or more weeks
after injury. As much as 30% of patients do not have
x-ray abnormalities. Bone scans may be characteristic
and may help to confirm CRPS but are not pathogno-
monic. Three-phase scans have been used but are in-
sufficiently sensitive. First- and second-phase bone
FIGURE 2: Radiograph of a patient with type 1 CRPS after
fracture of the distal radius and ulna. Diffuse osteopenia in
addition to juxtacortical demineralization and subchondral
erosions and cysts is present.scans may demonstrate asymmetry of flow dynamics
JHS Vol A, Seand quantify vasomotor instability and abnormal auto-
nomic flow. When positive, third-phase scans demon-
strate increased periarticular uptakes in involved and
uninvolved joints. A positive third-phase (bone scan–
positive) scan adds credence to the clinical diagnosis
and defines a subgroup of CRPS; however, it has lim-
ited prognostic importance.9
Thermoregulatory and nutritional blood flow testing
permits a qualitative and quantitative assessment of
distal-extremity autonomic function. A form of stress
(thermal or emotional) improves reliability and repro-
ducibility of this testing. Isolated cold stress testing
using both temperature and laser Doppler fluxmetry has
been described to assess dynamic sympathetic response
of an extremity to changes in environmental tempera-
ture. Skin surface temperature is a reflection of total
blood flow and laser Doppler evaluates rapid shunting
and nutritional flow (Fig. 3). Isolated cold stress testing
is sensitive to vasomotor disturbances that occur in 80%
to 90% of patients with CRPS; however, it is not
specific for CRPS.10 The normal response to cold or
alternative stress is predictable and reproducible. In
normal subjects, temperature and laser Doppler follow
(LDF) parallel response curves. At normal baseline,
temperatures will be stable; temperature and LDF will
fall during cooling in parallel fashion and will rebound
during warming to equal or greater than baseline. In
“high-flow” or warm CRPS, temperatures remain ele-
vated during cooling and rebound slightly and vary
from digit to digit. Laser Doppler follow characteristi-
cally drops randomly compared with baseline and fluc-
tuates during cooling. Both temperature and LDF are
increased during warming. In contradistinction, “low-
flow” or cool CRPS temperature is low during baseline,
cooling, and rewarming, with variation between fingers.
Laser Doppler follow follows temperature.
Vital capillaroscopy permits the direct measurement
of nutritional blood flow in the nailfold of the hand and
foot. Patients with CRPS demonstrate consistently de-
creased nutritional flow and are unable to modulate
flow compared with normal patients. Data from vital
capillaroscopy demonstrate decreased nutritional flow
in both “warm” and “cool” patients. Decreased nutri-
tional flow also supports irreversible damage to arterio-
venous shunts, thereby reducing appropriate nutritional
distribution in chronic, longstanding CRPS.
Pseudomotor function may be evaluated by a quan-
titative and qualitative assessment of sweat production
by measuring resting sweat output (RSO). Resting
sweat output measures sweat production before or after
a sympathetic block; it is primarily a research tool.
Quantitative pseudomotor axon reflex correlates highly
ptember 
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tswith the RSO. When the RSO and the quantitative
pseudomotor axon reflex are combined, consistent dif-
ferentiation of abnormal autonomic function in patients
with CRPS is possible (statistically significant,
P.003).
Thermography is an elegant and accurate measure-
ment of temperature. Because it reflects only total flow,
inherent limitations are the inability to evaluate vaso-
motor and nutritional flow.
Endurance testing is an effective technique to docu-
ment subtle functional deficits and is performed using
computerized equipment. Use of these techniques per-
mits the demonstration of objective signs of weakness
and fatigue not possible with the use of static testing.
Endurance testing is extremely accurate and difficult to
falsify and may demonstrate functional impairment that
would otherwise be missed.
Evaluation of sympathetically maintained pain
Common diagnostic procedures include stellate gan-
glion blocks, continuous autonomic plexus blocks, and
cervical epidural block. Intravenous phentolamine,
which blocks 1 and 2 receptors, provides a sympa-
tholytic effect and is the reference standard to determine
CRPS. Many oral drugs exhibit sympatholytic action.
Relief suggests SMP syndrome. Therefore, a positive
FIGURE 3: Isolated cold stress test combining digital temperatu
are monitored with thermistors attached to each digit of both
laser Doppler probe attached to 1 digit of each extremity. D
sampled using custom computer software; the results of the testresponse (relief of symptoms) supports the diagnosis of
JHS Vol A, SeCRPS and a negative response (persistent pain) sug-
gests an alternative diagnosis or irreversible peripheral
changes with or without central pain. Peripheral nerve
conduction velocities and electromyography may be
used to identify neuropathic conditions.
Classification and staging
Complex regional pain syndrome constitutes a series of
reversible and irreversible physiologic events; the time
course of these events is determined by the nature of the
initiating trauma, inherent physiologic adaptations, and
pre-existing comorbidities, therapeutic interventions,
and environment episodes. It is crucial to remember that
the results of therapeutic intervention may be unantic-
ipated.
Existing classifications do not suggest specific inter-
ventions or provide prognostic consequence. Proposed
classifications include those of de Takats in 193711 and
Steinbrocker in 1958.12 In general, staging based on
time is misleading. Because most patients are treated
before definitive diagnosis, classifications based on
temporal (time in weeks or months) factors are incon-
sistent and clinically irrelevant.
Prevention
A randomized, double-blinded, controlled trial using
nd laser Doppler fluxmetry measurements. Digital temperatures
emities. Microvascular cutaneous perfusion is assessed with a
l temperature and laser Doppler fluxmetry measurements are
plotted for analysis.re a
extr
igitavitamin C in patients with nonoperatively managed
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tswrist fractures demonstrated a lower incidence of CRPS
in the vitamin C group (7%) versus the placebo group
(22%).13 Another randomized, placebo-controlled, dou-
ble-blinded trial found that patients with wrist fractures
treated operatively and nonoperatively had a decreased
risk of CRPS in the vitamin C groups (overall 2.4%)
compared with the placebo group (10.1%).14 The rec-
ommended dose is 500 mg daily for 50 days after
injury, as a lower dose of 200 mg daily had an incidence
of CRPS of 4.2%, whereas the 500-mg group was
1.8%, which was similar to the 1,500-mg daily group
(1.7%). Although claims that vitamin C may reduce the
incidence of CRPS after distal radius fractures are con-
troversial, vitamin C has no major morbidity, is inex-
pensive, and is recommended in the American Acad-
emy of Orthopaedic Surgeons Clinical Guideline.15
Treatment
Treatment or referral for treatment should be initiated
on recognition and may be guided by clinical and di-
agnostic tests to determine the physiologic stage, the
presence or absence of sympathetically maintained
pain, and the presence or absence of a correctible no-
ciceptive or neuropathic event.
Management options include therapy, vitamins, oral
medications, parenteral medications, psychological
support, and surgery.
Physiologic staging evaluates the extent of arterio-
venous shunting and swelling and may be characterized
as high-, normal-, or low-flow states. Patients with high
flow states present clinically with a hot, swollen, and
painful extremity; increased total flow and inappropri-
ate arteriovenous shunting coincide with ischemic-like
pain (burning and tearing). This presentation is often
early, rarely has had irreversible events and fixed con-
tracture, is usually sympathetically maintained, and
does not respond well to narcotics.
Normal state is the most difficult to diagnose clini-
cally; the hand is not swollen but is painful. Diffuse
stiffness, hyperpathia, allodynia, and hyperalgesia are
common. Vasomotor tone is abnormal and nutritional
flow is low. Narcotics have limited efficacy.
In a low-flow state, the extremity is atrophic and
stiff. Pain is diffuse with a tearing or burning quality,
vasomotor tone is abnormal, function is impaired se-
verely, and nutritional deprivation exists.
Presence or absence of SMP is determined by im-
provement or lack thereof in symptoms after sympatho-
lytic oral medications, intravenous phentolamine, or
autonomic blocks. Sympathetically maintained pain is
supported by pain relief after oral sympatholytics (eg,
antidepressants and anticonvulsants) with diminution of
JHS Vol A, Sepain, conversion of diffuse pain to anatomic der-
matomes, or distributions. If oral medications are inad-
equate, Phentolamine or autonomic blocks are used.
Although many references suggest stellate blocks as a
reference standard, continuous blocks are more reliable
and provide more definitive diagnosis, in our experi-
ence.
Nociceptive or neuropathic injury or abnormality, if
corrected, will often ameliorate symptoms; however,
sympatholytic treatment may be necessary to identify
mechanical derangements or nerve abnormalities.
TREATMENT SEQUENCES
Often multiple modalities are used simultaneously and
sequentially. Therapy and oral medications are the first
line of treatment. The choice of oral medications may
be guided by the physiologic stage, with modification
based on patient variability. Except for pregabalin
(Lyrica; Pfizer, New York, NY), antidepressants, anti-
convulsants, adrenergic agents, and calcium channel
blockers are not designated by the Food and Drug
Administration for use to treat pain.
The following is provided as a guide to initial phar-
macologic and therapy care.
1. High-flow extremities are treated with therapy in-
cluding contrast baths and stress loading, and a
low-dose antidepressant and a low-dose anticon-
vulsant.
2. Normal flow is treated with therapy including
stress loading, contrast baths, and transcutaneous
electrical nerve stimulation units, and a low-dose
anticonvulsant and a calcium channel blocker.
3. A stiff, painful, cold hand indicates low flow.
Therapy consists of active and passive range of
motion and a transcutaneous electrical nerve stim-
ulation unit combined with an anticonvulsant and
calcium channel blocker.
3. High flow with localized hyperpathia may be
treated with a clonidine patch to the hyperpathic
area.
These are recommendations for initial care. Other
choices are well justified. It is important that the prac-
titioner understands the risks and benefits of these pow-
erful pharmacologic agents, appreciates drug interac-
tions, and monitors the patient carefully. Referral is
appropriate at any point of care.
Psychological management
Psychological pain interventions (especially cognitive
behavioral techniques) provide notable pain relief in
many chronic pain syndromes.16 Even though CRPS
has not been studied specifically using such interven-
tions, consensus and expert opinion state that these
ptember 











tsmethods are important adjuncts in the management of
CRPS.17
Therapy
Therapy and adaptive modalities are combined usually
with oral medications. These include hand therapy with
active and passive range of motion exercises (within
limits of pain), stress loading (scrubbing), splints, con-
trast baths (alternating heat and cold), and transcutane-
ous nerve stimulators. A randomized clinical trial dem-
onstrated that functional therapies may improve
symptoms in CRPS.18 Another recent controlled trial
using 2-point tactile discrimination training while ob-
serving a mirror image of the unaffected limb showed
significant improvement in both pain and 2-point sen-
sation in the affected extremity.19
Pharmacologic therapy
Oral pharmacologic interventions, which provide a
TABLE 2. Oral Medications
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Gabapentin (Neurontin; Pfizer
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Corticosteroids 20–80 mg/d; prednisone
equivalents  5–40 d
Stabilize m
nutrition
inflammsympatholytic effect and improve nutritional flow, are
JHS Vol A, Seused in the treatment of CRPS. Of note, none are
labeled by the Federal Drug Administration for use
in CRPS. Multiple classes of drugs are appropriate and
include corticosteroids, antidepressants, anticonvul-
sants, membrane-stabilizing agents, adrenergic agents,
and calcium channel blockers (Table 2). Injectable
medications may also be used in selected patients.
Corticosteroids
Many hand surgeons avoid corticosteroids because of
concern about avascular necrosis. However, many med-
ical practitioners consider corticosteroids to be the drug
of choice. Evidence suggests a low risk of avascular
necrosis with 1 or 2 courses or prednisone or its equiv-
alent. Steroids have efficacy, are inexpensive, and are
easily monitored. Increased blood sugar, especially in
diabetics, is a concern. Small randomized, controlled
trials indicate that a pulse of corticosteroids may im-
nism
Major Short-term Disadvantage




























































atoryprove symptoms in CRPS.20,21
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Neuroleptics (eg, gabapentin, pregabalin) have mild
analgesic effects, sympatholytic actions at a low dose,
and efficacy in CRPS.22 The doses used in CRPS are
lower than necessary for prevention of seizures. The
time course is shorter and the complication profile is
acceptable.
Antidepressants
Antidepressants—especially tricyclics—exert a sym-
patholytic effect and improve nutritional blood flow.
Effective doses are generally lower than required for
depression. Sedation is common, and for the short-term,
often beneficial. Bedtime dosing alone may have effi-
cacy. Tardive dyskinesia is a rare complication.
A meta-analysis indicates that antidepressants are
effective in non-CRPS neuropathic pain, with greater
efficacy of tricyclics compared with selective-serotonin
update inhibitors.23 Although antidepressants have not
specifically been tested in CRPS, anecdotally their ef-
ficacy has been noted.
Narcotics
Opioids have minimal effect on pain derived from
CRPS. A randomized controlled trial in CRPS com-
pared sustained release morphine versus placebo, with
no difference in pain over an 8-day period.24
Parenteral medications
N-methyl-D-aspartate (NMDA) blockers: Ketamine has a
mechanism of action consisting of NMDA receptor
blockade, which has a role in the treatment of severe
cases of centrally mediated neuropathic pain, such as
CRPS. The NMDA receptor blockade improves the
central sensitization component of CRPS, which in-
cludes symptoms of allodynia and hyperalgesia. Ket-
amine produces a state of dissociative anesthesia with
amnesia and analgesia. At high doses, side effects in-
clude hallucination, erratic behavior, and flashbacks.
There are 3 techniques for ketamine administra-
tion: intravenous subanesthetic dosing,25,26 intra-
venous high-dose anesthesia (“ketamine coma”),27
and topical administration.28
A randomized, placebo-controlled study showed that
a 4-day inpatient infusion of subanesthetic ketamine
produced markedly greater pain relief than placebo;
however, this benefit was lost by week 12 and there was
no improvement in function.25 A nonrandomized trial
of high-dose intravenous ketamine for 5 days demon-
strated substantial pain improvement compared with
baseline for 6 months after treatment.27 Without ade-
quate controlled trials, ketamine coma treatment for
JHS Vol A, SeCRPS should be viewed cautiously. Another double-
blinded, placebo-controlled, randomized trial showed
that topical ketamine notably reduced allodynia and
hyperalgesia.28 Topical ketamine does not elevate se-
rum ketamine levels, and side effects are minimized,
thereby allowing potential outpatient use.
Autonomic/sympathetic blockade: Sympathetic blockade is
often used in CRPS and has beneficial effects that are
short-lived. It provides important diagnostic informa-
tion with noteworthy improvement in sympathetically
maintained CRPS. Furthermore, it allows the physician
to perform a more thorough physical examination, po-
tentially finding a nociceptive focus, which may be
amenable to surgical intervention.
Invasive treatments
Spinal cord stimulation (SCS) requires the implantation
of electrodes in the epidural space and is designed to
stimulate the dorsal column at the level of the spinal
cord affected by CRPS. A 5-year follow-up of the only
randomized, controlled trial using SCS in patients with
CRPS demonstrated no statistical difference in pain or
quality of life scores in those who received SCS with
therapy compared with those who had therapy alone.29
Spinal cord stimulation is costly and invasive and has a
relatively high complication rate with minimal benefit
at 5 years. Nevertheless, based on multiple case control
studies and anecdote, implanted stimulators are used
frequently, with repeated efficacy.
Surgical interventions
Surgery may be employed to correct a nociceptive or
neurologic initiation of pain in patients with CRPS.
Examples include carpal tunnel release after distal ra-
dius fracture complicated by carpal tunnel syndrome,
neuroma resection or repair, and distal radius malunion
or distal radioulnar joint reconstruction. Early surgical
treatment of an identifiable pain source is beneficial and
risks of CRPS exacerbation are negated by postopera-
tive continuous pain blocks and appropriate oral medi-
cations. Multidisciplinary management both preopera-
tively and postoperatively may improve outcomes with
the inclusion of appropriate hand therapy, psychologi-
cal treatment, and pain management. Hand therapy is
particularly important after release of finger contrac-
tures, intrinsic contracture, and arthrofibrosis. Typi-
cally, extension contractures of the metacarpophalan-
geal joints and mild flexion contracture of the proximal
interphalangeal joints occur; intrinsic muscle–tendon
contractures are common. Release of metacarpophalan-
geal joints has been criticized because long-term im-
provement averages 50% of intraoperative correction.
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tsHowever, this improvement has a potential impact on
quality of life and function. After release, it is important
to evaluate intrinsic resting length. If it is contracted,
release of intrinsic contractures enhances grasp and
release. Individualized therapy regimens are critical and
may include active and passive range of motion, con-
trast baths, transcutaneous electrical nerve stimulation,
fluid therapy, splinting, continuous passive range of
motion, and intermittent positive pressure. The goal of
therapy should be to minimize swelling, increase range
of motion, desensitize the nociceptive focus, and de-
crease pain.
MYTHS AND DISINFORMATION
“CRPS is a psychiatric condition.”
There is abundant evidence to dispute this statement,
and its use is pejorative and will cause animosity and ill
will. It is not defensible in deposition or trial.
“CRPS spreads though the body.”
“Spread” is rare except on the Internet.
“Surgery is never appropriate.”
Surgery is appropriate in many instances—especially to
correct nociceptive and neurologic foci when pain is
controlled by pharmacologic interventions.
“The clinical picture is straightforward.”
It is not straightforward; subtle or variant forms of
CRPS are common and inadvertent treatment alters the
natural history.
PEARLS OF TREATMENT
● Recognize that CRPS may be present in patients
who have pain that does not respond to narcotics,
who have trouble sleeping, and who are stiff.
● Shoulder adhesive capsulitis is common and treat-
ment will improve outcomes.
● Double crush occurs. Evaluate for cervical abnor-
malities, thoracic outlet, and proximal compres-
sion neuropathy
● Do not rely on courses of stellate blocks. If
patients are not improving, request continuous
blocks.
● Use multimodal therapy early with combinations
of oral medications and therapy.
● If SMP is controllable with sympatholytic medi-
cations, surgery is appropriate.
● Document whether CRPS was considered in all
patients with excessive or unexplained pain inten-
sity. Then document again.
JHS Vol A, Se● Hand posturing in CRPS, in most, includes meta-
carpophalangeal extension and proximal interpha-
langeal in slight flexion or extension. A clenched
fist suggests an alternative diagnosis.
● Referral to a pain specialist is appropriate if con-
cern about diagnosis or response to treatment
persists.
Complex regional pain syndrome should be consid-
ered in any patient with excessive or seemingly inap-
propriate pain. Suspicion and inclusion of CRPS in the
differential diagnosis of unexplained or excessive pain
are suggested. Early pharmacologic treatment based on
the physiology combined with hand therapy is an ap-
propriate initial treatment. It is appropriate for paren-
teral management to refer to pain specialists if symp-
toms and signs persist. Evaluation for surgically
correctable problems and surgery under pharmacologic
protection is appropriate. Patient-centered care is essen-
tial.
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